Maturing differentiated human pluripotent stem cells in vitro: methods and challenges

D Ottaviani, M Ter Huurne, DA Elliott, M Bellin… - …, 2023 - journals.biologists.com
Human pluripotent stem cells (hPSCs), derived from individuals or genetically modified with
disease-related mutations and variants, have revolutionised studies of human disease …

Heart in a dish – choosing the right in vitro model

L Drakhlis, R Zweigerdt - Disease Models & Mechanisms, 2023 - journals.biologists.com
The heart is the first functional organ established during embryogenesis. Investigating heart
development and disease is a fascinating and crucial field of research because …

Report of the assay guidance workshop on 3-dimensional tissue models for antiviral drug development

R Jordan, SL Ford-Scheimer… - The Journal of …, 2023 - academic.oup.com
Abstract The National Center for Advancing Translational Sciences (NCATS) Assay
Guidance Manual (AGM) Workshop on 3D Tissue Models for Antiviral Drug Development …

[HTML][HTML] Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA …

C Correia, J Christoffersson, S Tejedor, S El-Haou… - Cells, 2024 - mdpi.com
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) constitute an appealing
tool for drug discovery, disease modeling, and cardiotoxicity screening. However, their …

Injection of IK1 through dynamic clamp can make all the difference in patch-clamp studies on hiPSC-derived cardiomyocytes

AO Verkerk, R Wilders - Frontiers in physiology, 2023 - frontiersin.org
Human-induced stem cell-derived cardiomyocytes (hiPSC-CMs) are a valuable tool for
studying development, pharmacology, and (inherited) arrhythmias. Unfortunately, hiPSC …

Cell-cell interactions in the heart: advanced cardiac models and omics technologies

S Tan, J Yang, S Hu, W Lei - Stem Cell Research & Therapy, 2024 - Springer
A healthy heart comprises various cell types, including cardiomyocytes, endothelial cells,
fibroblasts, immune cells, and among others, which work together to maintain optimal …

[HTML][HTML] Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes

K Kistamás, A Müller, S Muenthaisong… - Journal of Molecular …, 2023 - Elsevier
Cardiovascular diseases are the leading cause of death worldwide. Several strategies–
small molecules, gene therapy, surgeries, cardiac rehabilitation–have been developed to …

Engineering multicellular living systems—A keystone Symposia report

J Cable, P Arlotta, KK Parker, AJ Hughes… - Annals of the New …, 2022 - Wiley Online Library
The ability to engineer complex multicellular systems has enormous potential to inform our
understanding of biological processes and disease and alter the drug development process …

Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels

M Pierre, M Djemai, CA Chapotte-Baldacci… - Frontiers in …, 2023 - frontiersin.org
Myotonic dystrophy type 1 (DM1) is a genetic disorder that causes muscle weakness and
myotonia. In DM1 patients, cardiac electrical manifestations include conduction defects and …

Stem cell therapy for cardiac regeneration: past, present, and future

JK Gill, SK Rehsia, E Verma, N Sareen… - Canadian Journal of …, 2024 - cdnsciencepub.com
Cardiac disorders remain the leading cause of mortality worldwide. Current clinical
strategies, including drug therapy, surgical interventions, and organ transplantation offer …